BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11972716)

  • 21. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inorganic Polyphosphate Amplifies High Mobility Group Box 1-Mediated Von Willebrand Factor Release and Platelet String Formation on Endothelial Cells.
    Biswas I; Panicker SR; Cai X; Mehta-D'souza P; Rezaie AR
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1868-1877. PubMed ID: 29930000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of von Willebrand factor and endothelin-1 on formation of thrombotic status in patients with ischemic heart disease].
    Sokolov EI; Grishina TI; Shtin SR
    Kardiologiia; 2013; 53(3):25-30. PubMed ID: 23548423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.
    Cooney KA; Lyons SE; Ginsburg D
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markers of endothelial perturbation and damage.
    Pearson JD
    Br J Rheumatol; 1993 Aug; 32(8):651-2. PubMed ID: 8348264
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytokines, fibrinolysis and vasculitis.
    Teofoli P; Lotti T
    Int Angiol; 1995 Jun; 14(2):125-9. PubMed ID: 8609438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes.
    Carlson JA; Chen KR
    Am J Dermatopathol; 2007 Feb; 29(1):32-43. PubMed ID: 17284960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shear stress-induced binding of von Willebrand factor to platelets.
    Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
    Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical features of 32 patients with cutaneous small vessel vasculitis].
    López de Maturana D; Amaro P; Segovia L; Balestrini C
    Rev Med Chil; 2004 Feb; 132(2):165-70. PubMed ID: 15449552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes.
    Carlson JA; Chen KR
    Am J Dermatopathol; 2006 Dec; 28(6):486-506. PubMed ID: 17122493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
    Ji S; Jiang M; Yan B; Shen F; He Y; Wan A; Xia L; Ruan C; Zhao Y
    J Hematol Oncol; 2017 May; 10(1):111. PubMed ID: 28526067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cutaneous vasculitis and vasculopathy : Differential diagnosis in biopsies of the lower extremities].
    Holl-Ulrich K; Rose C
    Pathologe; 2020 Jul; 41(4):355-363. PubMed ID: 32377833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies.
    Frontroth JP; Favaloro EJ
    Methods Mol Biol; 2017; 1646():473-494. PubMed ID: 28804849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelets and von Willebrand factor.
    Schmugge M; Rand ML; Freedman J
    Transfus Apher Sci; 2003 Jun; 28(3):269-77. PubMed ID: 12725954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the mechanism of plasmin-induced aggregation of human platelets: implication of secreted von Willebrand factor.
    Rabhi-Sabile S; de Romeuf C; Pidard D
    Thromb Haemost; 1998 Jun; 79(6):1191-8. PubMed ID: 9657447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological findings in cutaneous small-vessel vasculitis associated with solid-organ malignancy.
    Podjasek JO; Wetter DA; Wieland CN; Camilleri MJ; Lohse CM
    Br J Dermatol; 2014 Dec; 171(6):1397-401. PubMed ID: 24958433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased shear stress- and ristocetin-induced binding of von Willebrand factor to platelets in cord compared with adult plasma.
    Rehak T; Cvirn G; Gallistl S; Leschnik B; Köstenberger M; Katzer H; Ribitsch V; Muntean W
    Thromb Haemost; 2004 Oct; 92(4):682-7. PubMed ID: 15467896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall].
    Meyer D
    Nouv Rev Fr Hematol (1978); 1982; 24(3):145-51. PubMed ID: 6752879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.